DURHAM, N.C.–(BUSINESS WIRE)– #ClinicalWorkflow–Based on the company’s leading ophthalmology EHR and PM solution, Sightview has launched a platform for ophthalmologists with user-favorite workflows.
Author: Business Wire
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that two of its pharmaceutical pipeline assets – both first-in-cla…
Eyebot and QUAY Join Forces to Install In-Store Vision Test Kiosks in Southern California Locations
BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Eyebot, the automated vision test kiosk that provides doctor-verified eyeglass prescriptions, today announced a strategic partnership with QUAY, the global eyewear brand known for on-trend design and premium mat…
Ingenia Therapeutics Nominated for Both the Prix Galien USA and the Inaugural Prix Galien Korea for Best Startup
WATERTOWN, Mass.–(BUSINESS WIRE)–Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, today announced that it has been nominated for the Prix Galien USA and the inaugural Prix Galien Kor…
Glaukos Announces Participation in Wells Fargo Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that …
Bridging Clinical Practice and Drug Development, Ora Appoints Dr. John Trein as Therapeutic Lead, Posterior
BOSTON–(BUSINESS WIRE)– #ClinicalResearch–Ora, the world’s leading ophthalmic contract research organization, appoints retina specialist Dr. John Trein as Therapeutic Lead, Posterior
Stuart Therapeutics, Inc. Appoints David Jakeman as Chief Financial Officer
STUART, Fla.–(BUSINESS WIRE)–Stuart Therapeutics, Inc. (“Stuart”), a clinical-stage biopharmaceutical company developing first-in-class collagen-reparative therapeutics to treat eye diseases, today announced the appointment of David Jakeman as chief …
Ingenia Therapeutics Goes Public on KOSDAQ to Accelerate Pipeline of Next-Generation Vascular Antibody Therapeutics
WATERTOWN, Mass.–(BUSINESS WIRE)–Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced today that its shares have begun trading on the KOSDAQ market. The IPO marks a significant…
Experiences That Matter Foundation Receives the SBB Research Group Foundation Grant
CHICAGO–(BUSINESS WIRE)–Experiences That Matter Foundation received a $5,000 grant from the SBB Research Group Foundation, which awards monthly grants to support impactful organizations. Experiences That Matter Foundation, based in Chicago, Illinois,…
STAAR Surgical Reports Second Quarter 2026 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
STAAR Surgical Reports Second Quarter 2026 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
STAAR Surgical Reports Second Quarter 2026 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the second quarter ended Jul…
Azalea Vision nombra como director ejecutivo a su cofundador Andrés Vasquez Quintero para liderar su próxima fase de desarrollo clínico
GANTE, Bélgica–(BUSINESS WIRE)–Azalea Vision, una empresa de tecnología de salud belga, anunció hoy que su cofundador y director de tecnología, Andrés Vasquez Quintero, se convertirá en director ejecutivo, con efecto inmediato, además de continuar co…
Azalea Vision nomme son cofondateur, Andrés Vasquez Quintero, au poste de CEO pour mener à bien la nouvelle phase de son développement clinique
GAND, Belgique–(BUSINESS WIRE)–Azalea Vision, une entreprise belge dans le secteur des technologies de la santé, a annoncé aujourd’hui que son cofondateur et CTO Andrés Vasquez Quintero prendra ses nouvelles fonctions de CEO, avec prise d’effet imméd…
Azalea Vision nomina il co-fondatore Andrés Vasquez Quintero a Chief Executive Officer per guidare la prossima fase dello sviluppo clinico
GAND, Belgio–(BUSINESS WIRE)–Azalea Vision, una healthtech belga, oggi ha annunciato che il co-fondatore e CTO Andrés Vasquez Quintero assumerà il ruolo di Chief Executive Officer con effetto immediato, e manterrà anche la carica di CTO. Questa trans…
Azalea Vision nomme son cofondateur, Andrés Vasquez Quintero, au poste de CEO pour mener à bien la nouvelle phase de son développement clinique
GAND, Belgique–(BUSINESS WIRE)–Azalea Vision, une entreprise belge dans le secteur des technologies de la santé, a annoncé aujourd’hui que son cofondateur et CTO Andrés Vasquez Quintero prendra ses nouvelles fonctions de CEO, avec prise d’effet imméd…
Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development
GHENT, Belgium–(BUSINESS WIRE)–Azalea Vision, a Belgian healthtech company, today announced that co-founder and CTO Andrés Vasquez Quintero will become Chief Executive Officer, effective immediately, while continuing as CTO. The transition marks the …
Azalea Vision nombra como director ejecutivo a su cofundador Andrés Vasquez Quintero para liderar su próxima fase de desarrollo clínico
GANTE, Bélgica–(BUSINESS WIRE)–Azalea Vision, una empresa de tecnología de salud belga, anunció hoy que su cofundador y director de tecnología, Andrés Vasquez Quintero, se convertirá en director ejecutivo, con efecto inmediato, además de continuar co…
Azalea Vision ernennt Mitbegründer Andrés Vasquez Quintero zum Chief Executive Officer, um die nächste Phase der klinischen Entwicklung voranzutreiben
GENT, Belgien–(BUSINESS WIRE)–Azalea Vision, ein belgisches Healthtech-Unternehmen, gab heute bekannt, dass Mitbegründer und CTO Andrés Vasquez Quintero mit sofortiger Wirkung zum Chief Executive Officer ernannt wird, wobei er weiterhin als CTO tätig…
Azalea Vision benoemt medeoprichter Andrés Vasquez Quintero tot CEO om de volgende fase in klinische ontwikkeling te leiden
GENT, België–(BUSINESS WIRE)–Azalea Vision, een Belgisch healthtech-bedrijf, maakte vandaag bekend dat medeoprichter en CTO Andrés Vasquez Quintero met onmiddellijke ingang tot Chief Executive Officer is benoemd, terwijl hij verder als CTO actief bli…